Unlike drugs all vaccines need to be transported at cold temperatures (usually between 2 and 8 degrees Celsius) prior to use. the IISc-incubated biotech start-up Mynvax has successfully developed a Covid-19 vaccine which is stable under high-temperature environments and was found to be effective against all current SARS-CoV-2 variants of concern. Warm COVID-19 vaccine can withstand transient exposure to temperatures as high as 100 degrees Celsius and can be stored for over a month at 37 degrees Celsius.
Sources : IISc
0 Comments
Leave a Reply. |
Archives
October 2021
Categories
All
|